Efficacy and safety of PD-L1 inhibitors versus PD-1 inhibitors in first-line treatment with chemotherapy for extensive-stage small-cell lung cancer
Yu, Hui, Chen, Ping, Cai, Xiuyu, Chen, Chen, Zhang, Xuanye, He, Lina, Zhou, Yixin, Hong, Shaodong, Zhang, Bei
Published in Cancer Immunology, Immunotherapy (01.03.2022)
Published in Cancer Immunology, Immunotherapy (01.03.2022)
Get full text
Journal Article
Simulation and Error Analysis of Methane Detection Globally Using Spaceborne IPDA Lidar
Zhang, Xuanye, Zhang, Miaomiao, Bu, Lingbing, Fan, Zengchang, Mubarak, Ahmad
Published in Remote sensing (Basel, Switzerland) (01.07.2023)
Published in Remote sensing (Basel, Switzerland) (01.07.2023)
Get full text
Journal Article
Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma
Cai, Jun, Liu, Panpan, Huang, Huiqiang, Li, Yajun, Ma, Shuyun, Zhou, Hui, Tian, Xiaopeng, Zhang, Yuchen, Gao, Yan, Xia, Yi, Zhang, Xuanye, Yang, Hang, Li, Lirong, Cai, Qingqing
Published in Signal transduction and targeted therapy (30.12.2020)
Published in Signal transduction and targeted therapy (30.12.2020)
Get full text
Journal Article
Hepatitis B virus reactivation in cancer patients with positive Hepatitis B surface antigen undergoing PD-1 inhibition
Zhang, Xuanye, Zhou, Yixin, Chen, Chen, Fang, Wenfeng, Cai, Xiuyu, Zhang, Xiaoshi, Zhao, Ming, Zhang, Bei, Jiang, Wenqi, Lin, Zuan, Ma, Yuxiang, Yang, Yunpeng, Huang, Yan, Zhao, Hongyun, Xu, Ruihua, Hong, Shaodong, Zhang, Li
Published in Journal for immunotherapy of cancer (21.11.2019)
Published in Journal for immunotherapy of cancer (21.11.2019)
Get full text
Journal Article
Hepatotoxicity associated with PD-1 blockade antibodies in cancer patients co-infected with hepatitis B virus
Lin, Zuan, Zhang, Xuanye, Zhou, Yixin, Chen, Chen, He, Li-na, Li, Haifeng, Wang, Yuhong, Chen, Tao, Hong, Shaodong, Zhang, Li
Published in Cancer Immunology, Immunotherapy (01.05.2022)
Published in Cancer Immunology, Immunotherapy (01.05.2022)
Get full text
Journal Article
Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients
Zhang, Xuanye, Rao, Huilan, Xu, Xiaolu, Li, Zhihua, Liao, Bing, Wu, Hongmei, Li, Mei, Tong, Xiuzhen, Li, Juan, Cai, Qingqing
Published in Cancer science (01.01.2018)
Published in Cancer science (01.01.2018)
Get full text
Journal Article
Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis
Zhou, Yixin, Chen, Chen, Zhang, Xuanye, Fu, Sha, Xue, Cong, Ma, Yuxiang, Fang, Wenfeng, Yang, Yunpeng, Hou, Xue, Huang, Yan, Zhao, Hongyun, Hong, Shaodong, Zhang, Li
Published in Journal for immunotherapy of cancer (22.12.2018)
Published in Journal for immunotherapy of cancer (22.12.2018)
Get full text
Journal Article
Correction to: Hepatotoxicity associated with PD-1 blockade antibodies in cancer patients co-infected with hepatitis B virus
Lin, Zuan, Zhang, Xuanye, Zhou, Yixin, Chen, Chen, He, Li-na, Li, Haifeng, Wang, Yuhong, Chen, Tao, Hong, Shaodong, Zhang, Li
Published in Cancer Immunology, Immunotherapy (01.05.2022)
Published in Cancer Immunology, Immunotherapy (01.05.2022)
Get full text
Journal Article
Spectral Efficient Neural Network-Based M-ary Chirp Spread Spectrum Receivers for Underwater Acoustic Communication
Liu, Songzuo, Zuberi, Habib Hussain, Arfeen, Zuhair, Zhang, Xuanye, Bilal, Muhammad, Sun, Zongxin
Published in Arabian journal for science and engineering (2011) (2024)
Published in Arabian journal for science and engineering (2011) (2024)
Get full text
Journal Article
LRRC3B and its promoter hypomethylation status predicts response to anti-PD-1 based immunotherapy
Luo, Linfeng, Fu, Sha, Du, Wei, He, Li-Na, Zhang, Xuanye, Wang, Yixing, Zhou, Yixin, Hong, Shaodong
Published in Frontiers in immunology (24.01.2023)
Published in Frontiers in immunology (24.01.2023)
Get full text
Journal Article
Adjuvant therapy in completely resected, EGFR-mutant non-small cell lung cancer: a comparative analysis of treatment efficacy between EGFR-TKI and anti-PD-1/PD-L1 immunotherapy
Li, Zichun, Zhang, Xuanye, Wang, Yuhong, Yu, Zhixin, Yang, Chunlong, Zhou, Yixin, Hong, Shaodong
Published in Journal for immunotherapy of cancer (01.10.2023)
Published in Journal for immunotherapy of cancer (01.10.2023)
Get full text
Journal Article
PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma
Zhang, Xuanye, Zhou, Yixin, Chen, Hualin, Chen, Chen, Lin, Zuan, He, Li-na, Du, Wei, Chen, Tao, Hong, Shaodong, Fu, Sha
Published in Frontiers in immunology (29.09.2022)
Published in Frontiers in immunology (29.09.2022)
Get full text
Journal Article
Continuation of anti-PD-1 therapy plus physician-choice treatment beyond first progression is not associated with clinical benefit in patients with advanced non-small cell lung cancer
Wang, Yixing, Fu, Sha, Zhang, Xuanye, Du, Wei, Luo, Linfeng, Jiang, Yongluo, Zhou, Yixin, Zhao, Yuanyuan, Yang, Yunpeng, Zhao, Hongyun, Fang, Wenfeng, Huang, Yan, Zhang, Li, Hong, Shaodong
Published in Frontiers in immunology (29.05.2023)
Published in Frontiers in immunology (29.05.2023)
Get full text
Journal Article
Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor
He, Li-Na, Chen, Tao, Fu, Sha, Jiang, Yongluo, Zhang, Xuanye, Chen, Chen, Du, Wei, Luo, Linfeng, Li, Anlin, Wang, Yixing, Yu, Hui, Zhou, Yixin, Wang, Yuhong, Yang, Yunpeng, Huang, Yan, Zhao, Hongyun, Fang, Wenfeng, Zhang, Li, Hong, Shaodong
Published in Therapeutic advances in medical oncology (01.01.2023)
Published in Therapeutic advances in medical oncology (01.01.2023)
Get full text
Journal Article
PD-1/PD-L1 inhibitor plus chemotherapy versus bevacizumab plus chemotherapy in first-line treatment for non-squamous non-small-cell lung cancer
Yu, Hui, Chen, Ping, Xia, Liangping, Fu, Sha, Chen, Chen, Zhang, Xuanye, He, Lina, Zhang, Bei, Zhou, Yixin, Hong, Shaodong
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis
Wu, Hongyu, Wang, Jianwei, Zhang, Xuanye, Yang, Hang, Wang, Yu, Sun, Peng, Cai, Qingqing, Xia, Yi, Liu, Panpan
Published in Frontiers in oncology (20.10.2020)
Published in Frontiers in oncology (20.10.2020)
Get full text
Journal Article
Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy
He, Li-Na, Zhang, Xuanye, Li, Haifeng, Chen, Tao, Chen, Chen, Zhou, Yixin, Lin, Zuan, Du, Wei, Fang, Wenfeng, Yang, Yunpeng, Huang, Yan, Zhao, Hongyun, Hong, Shaodong, Zhang, Li
Published in Frontiers in oncology (19.01.2021)
Published in Frontiers in oncology (19.01.2021)
Get full text
Journal Article
Unsatisfied Reporting Quality of Clinical Trials Evaluating Immune Checkpoint Inhibitor Therapy in Cancer
Chen, Chen, Zhou, Yixin, Zhang, Xuanye, Wang, Yuhong, He, Li-Na, Lin, Zuan, Chen, Tao, Jiang, Yongluo, Hong, Shaodong, Zhang, Li
Published in Frontiers in immunology (05.10.2021)
Published in Frontiers in immunology (05.10.2021)
Get full text
Journal Article
Second‐line treatment options in advanced thymic carcinoma after failure of platinum‐based chemotherapy: A multicenter retrospective study
Wang, Yang, Zhang, Xuanye, Tian, Dan, Han, Sen, Zhang, Jie, Nie, Jun, Dai, Ling, Hu, Weiheng, Chen, Xiaoling, Ma, Xiangjuan, Tian, Guangming, Wu, Di, Zhang, Ziran, Long, Jieran, Fang, Jian
Published in Cancer medicine (Malden, MA) (01.02.2023)
Published in Cancer medicine (Malden, MA) (01.02.2023)
Get full text
Journal Article